Sequoia Sciences

Developing novel vaccines and anticancer compounds for bacterial infections and cancer

placeSaint Louis, Missouri, United States calendar_todayFounded 1999 groups16 employees language sequoiasciences.com

Registered entities

Innovation

19 patent families (12 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies; filing pace slowing. Cited 2,156 times.

YearFilings
20122
20131
20141
20154
20168
20175
20182
20191
20201
20231

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital360%
Angel & family office120%
Other / undisclosed120%
Coming soon